CARLSBAD, Calif., June 12 /PRNewswire/ -- GenVault Corporation today announces Paul J. Mirabella, Chairman and CEO of Naviscan PET Systems Inc., has joined its Board of Directors. Mr. Mirabella has more than 30 years of experience in diagnostic imaging with GE Healthcare where he held leadership roles in technology, marketing and global business management. Drawing on this substantial background in diagnostics and the healthcare market, he will help guide GenVault's entry into new biosample management markets as well as streamline operational efficiencies.
"Mr. Mirabella's deep business experience and understanding of the healthcare industry will be extremely valuable as we develop new technologies to expand our addressable markets. We are extremely honored to welcome Mr. Mirabella as a key member of the GenVault team," said David Wellis, CEO of GenVault.
"Biosamples are the conduit of information from the patient to clinicians and researchers. Advances in the handling of these samples will result in more efficient diagnosis, therapy development and ultimately a healthier population. I'm pleased to participate in building such a critical solution," said Mr. Mirabella.
Mr. Mirabella's previous experience includes leadership roles at GE Healthcare in ultrasound, computed tomography (CT), magnetic resonance, and sales and services. Mr. Mirabella holds four patents in CT and has participated in a variety of successful global product launches. Prior to joining Naviscan, he was President and CEO of Global Diagnostic Imaging, while retaining responsibility for the commercial leadership of sales, marketing and services in the Americas. Mr. Mirabella obtained degrees in aerospace engineering and applied mechanics from Polytechnic Institute of New York and a Masters in mechanical engineering from the University of Central Florida. He is a graduate of the GE Business Management Program accredited by the University of Wisconsin-Whitewater.
Mr. Mirabella is also on the Board of Directors for the Vince Lombardi Charitable Funds in Milwaukee, the RSNA Research and Education Board, AMIRSYs, Inc., served on the Wisconsin Governor's Economic Council, and an owner/director of several private companies in Wisconsin.
GenVault is the global leader in providing biosample workflow,
transport, and storage solutions for genomic medicine, discovery and
identification. Today, GenVault is empowering over 150 pharmaceutical
companies, medical centers, academic institutions and law enforcement
agencies to more fully leverage the rapidly growing genomics industry. As a
scalable and reliable alternative to traditional freezers and DNA
purification systems, the company's dry state platform enables the
extraction, preservation, recovery, and distribution of DNA at room
temperature. Future systems will also accommodate proteins and RNA to
provide a comprehensive solution. From GenPlate to the Dynamic Archive,
GenVault is continuously developing and refining best practices for DNA
sample management and preservation. For more information visit GenVault at
David Wellis, CEO or
Kerri McWeeny, Director of Marketing
|SOURCE GenVault Corporation|
Copyright©2008 PR Newswire.
All rights reserved